TheBCDLabBCD

unh.

UNH 2026-08-30

Created on

Fundamental Report

COMPREHENSIVE VALUATION ANALYSIS: UNH

📊 CURRENT VALUATION METRICS: • Current PE Ratio: 25.22 • Current EPS: $6.04

📈 Z-SCORE ANALYSIS (Standard Deviations from Mean): • PE Z-score: +0.47 (around historical mean) • EPS Z-score: +1.08 (moderately above historical mean)

🎯 PERCENTILE RANKING (vs Historical): • PE Percentile: 75.7% 🟠 (high) • EPS Percentile: 85.0% 🔴 (very high)

📈 GROWTH METRICS: • EPS Growth (1-year): +133.2% • EPS Growth (2-year): -3.6% • EPS Trend: strongly increasing

💰 PEG RATIO ANALYSIS: • PEG Ratio: 0.19 (potentially undervalued (PEG < 0.5))

📅 HISTORICAL RANGES: • PE Range: 13.51 (min) to 38.04 (max), Mean: 22.83 • EPS Range: $-1.53 (min) to $6.91 (max), Mean: $4.05

🔍 TREND ANALYSIS: • PE Trend: stable • Current PE vs Mean: +10.5% • Current EPS vs Mean: +49.3%

⚖️ COMPREHENSIVE VALUATION ASSESSMENT: • Primary Assessment: MIXED SIGNALS: Valuation indicators show conflicting signals

📊 DATA CONTEXT: • Analysis Period: 2016-09-30 to 2026-06-30 • Data Points: 40 quarters • Latest Earnings Ending Date: 2026-06-30

Management Sentiment Summary for UNH in 2026Q2 earnings call:

The following is the average sentiment score for each management title:

The lower the score, the more negative the sentiment. The higher the score, the more positive the sentiment. 0.5 is neutral.

TitleSentiment Score
President, UnitedHealthcare Medicaid0.14
Executive Vice President and Chief Financial Officer, UnitedHealth Group0.32

Insider transactions for UNH in the last 90 days:

Total Amount Traded is negative for total net sale of shares. Positive for total net purchase of shares.

DateTotal Amount TradedAvg. Traded PriceTransaction TypeRemaining Shares
2026-08-21-1.2K$390.0Sell15.3K
2026-08-05-500$410.0Sell16.5K

Momentum Report

MOMENTUM ANALYSIS REPORT for UNH

Note: All indicators use daily closing prices by 2026-08-30 (inclusive)

INDICATOR TIME WINDOWS

  • Long-term EMAs: 50 & 200 days
  • Momentum Oscillators: 14 days (RSI, ADX)
  • Volatility: 20 days (Bollinger Bands)
  • Volume: 20-day average baseline

STRUCTURAL TREND (Long-Term: 2–12 months)

  • Direction: BULLISH
  • Strength: STRONG (EMA Gap: 10.59%)
  • Signal: Price relative to EMAs indicates long-term bias

INTERMEDIATE TREND (2–6 weeks)

  • Status: BEARISH
  • Price vs EMA50: Below
  • MACD Line: Bearish (<0)
  • Interpretation: Medium-term momentum direction

SHORT-TERM MOMENTUM (1–3 weeks)

  • Momentum: ACCELERATING BULLISH
  • Trend Strength (ADX 25.35): STRONG
  • MACD Histogram: 0.0691 (rising)
  • RSI Status: NEUTRAL (42.31)

VOLUME CONFIRMATION

  • OBV Trend: Bearish (Falling)
  • Recent Price Change: -0.53% (Bearish)
  • Volume-Price Relationship: DIVERGENCE (Price Down, Volume Down)
  • Volume Ratio: 0.61x 20-day average (LOW)

KEY LEVELS

  • Current Price: $392.95
  • Support (BB Lower): $384.33
  • Resistance (BB Upper): $415.82
  • Bollinger Position: 27.4%

ADVANCED MOMENTUM FACTORS

  • Returns Momentum (20D / 60D / 120D): -5.40% / -0.89% / 39.18%
  • Returns Regime: WEAK/CHOPPY
  • Relative Strength vs SPY: 0.98 (IN-LINE)
  • Volatility-Adjusted Momentum: -0.04 (NEGATIVE_MOMENTUM)
  • Momentum Persistence: 0.39 (CHOPPY)
  • Trend Quality (R²): 0.59 (MODERATE)

SYNTHESIS & REGIME

  • Overall Bias: NEUTRAL (-1/11 signal strength)
  • Regime Classification: REVERSAL ATTEMPT
  • Signal Conflicts: Present
  • Risk Assessment: NEUTRAL zone, STRONG trend

TRADING IMPLICATIONS

  1. Long-term Investors: Follow BULLISH trend, strong conviction
  2. Swing Traders: BEARISH with weak/diverging volume
  3. Short-term Traders: accelerating bullish momentum
  4. Risk Management: RSI in NEUTRAL zone, consider strong position sizing

SHORT INTEREST CONTEXT

Short interest data for UNH in the past 5 months:

Report Dateshort_interestavg_daily_volumedays_to_cover
2026-08-1415.5M4M3.84
2026-07-3115.1M6M2.52
2026-07-1517.3M5M3.46
2026-06-3018.4M6.9M2.65
2026-06-1517.2M7.4M2.31
2026-05-2919.3M6.4M3.04
2026-05-1517.5M6.8M2.58
2026-04-3019.5M10.1M1.93
2026-04-1515.2M8.1M1.88
2026-03-3117.7M9.8M1.80
2026-03-1317.8M7.4M2.42
2026-02-2714.8M8.1M1.83

REPORT CONFIDENCE: MEDIUM NEXT UPDATE: Consider monitoring for regime confirmation

Wyckoff Report

Swing Point & Trading Range Analysis for UNH

Daily data based on the past 90 trading days by 2026-08-30 (inclusive)

Current Price: $392.95

1. IDENTIFIED SWING POINTS

Swing Highs (3 total): • $404.15 on 2026-05-13 • $415.98 on 2026-06-10 • $461.62 on 2026-07-16

Swing Lows (5 total): • $358.25 on 2026-05-06 • $374.72 on 2026-06-02 • $398.59 on 2026-06-17 • $397.80 on 2026-08-05 • $383.83 on 2026-08-20

Recent Swing Points (Last 5): • HIGH: $415.98 on 2026-06-10 • LOW: $398.59 on 2026-06-17 • HIGH: $461.62 on 2026-07-16 • LOW: $397.80 on 2026-08-05 • LOW: $383.83 on 2026-08-20 Sequence: HIGH $415.98 → LOW $398.59 → HIGH $461.62 → LOW $397.80 → LOW $383.83

2. TRADING RANGE ANALYSIS

Current Trading Range (Last 90 Days): • Upper Boundary (Resistance): $461.62 • Lower Boundary (Support): $348.95 • Range Width: 32.3% • Range Established: 2026-04-27

Range Pattern Analysis: • No higher lows pattern detected • No lower highs pattern detected

Recent Swing Highs in Current Range: • $404.15 on 2026-05-13 (49% up from support) • $415.98 on 2026-06-10 (59% up from support) • $461.62 on 2026-07-16 (100% up from support)

Recent Swing Lows in Current Range: • $398.59 on 2026-06-17 (44% up from support) • $397.80 on 2026-08-05 (43% up from support) • $383.83 on 2026-08-20 (31% up from support)

3. KEY LEVELS SUMMARY

Major Levels: • Key Resistance: $461.62 • Key Support: $348.95

Near-term Resistance Levels: • $404.15 (nearest swing high above price) • $404.15 on 2026-05-13 • $415.98 on 2026-06-10 • $461.62 on 2026-07-16

Near-term Support Levels: • $383.83 (nearest swing low below price) • $383.83 on 2026-08-20

4. VOLUME CONTEXT

• Recent 7-day average Volume: 0.7x 50-day average • Below-average volume suggests consolidation

VOLUME PROFILE ANALYSIS REPORT Current Price: $392.95 (39.1% of price range)

POINT OF CONTROL (POC) ANALYSIS • Maximum Volume POC: $401.53 • POC Volume: 93.1M (17.0% of total) • Current Price Position: BELOW POC

VALUE AREA ANALYSIS • Value Area (70% volume): $363.97 - $424.06 • Value Area Width: $60.09 (15.3% of price) • Current Position: INSIDE Value Area

HIGH VOLUME NODES

  1. $401.53 (Supply Zone, above current) Volume: 93.1M (2.6x avg bin)
  2. $394.02 (Supply Zone, above current) Volume: 66.9M (1.8x avg bin)
  3. $424.06 (Supply Zone, above current) Volume: 65.7M (1.8x avg bin)
  4. $416.55 (Supply Zone, above current) Volume: 60.5M (1.7x avg bin)
  5. $379.00 (Demand Zone, below current) Volume: 58.6M (1.6x avg bin) Total 6 high volume nodes detected

LOW VOLUME NODES

  1. $356.46 (below current) Volume: 0 (0.0x avg bin)
  2. $439.09 (above current) Volume: 0 (0.0x avg bin)
  3. $446.60 (above current) Volume: 0 (0.0x avg bin)

WYCKOFF ANALYSIS INSIGHTS • Demand below, Supply above - Typical bullish structure • Price WITHIN Value Area - Fair value area • Low volume gaps on BOTH sides - Potential for volatile moves • Recent volume trend: decreasing (0.6x average) • Volume spikes detected on recent days: 5 occurrence(s)

TRADING IMPLICATIONS

  1. Value Area boundaries act as key support/resistance
  2. High Volume Nodes indicate institutional activity areas
  3. Low Volume Areas may see accelerated price movements
  4. Confirm volume signals with price action patterns
  5. POC represents fairest price where most volume traded

Divergence Report

DIVERGENCE ANALYSIS REPORT: UNH

Note: Report using data prior to 2026-08-30 Current Price: $392.95

EXECUTIVE SUMMARY

  • Overall Bias: MIXED SIGNALS - MARKET IN TRANSITION
  • Net Divergence Lean: +0.06 on a -1..+1 scale (-1 = every signal bearish, +1 = every signal bullish)
  • Evidence: 13 distinct indicator(s) diverging — 7 bullish, 6 bearish
  • Average Confidence: 83.5/100
  • Raw Score (unbounded, for traceability only — grows with signal count, do NOT read as conviction): +65.0
  • Market State: Trending with divergences

DETAILED DIVERGENCE SIGNALS

BULLISH DIVERGENCES (Potential Upside)

MACD_HISTOGRAM - BULLISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 14 & 20 days
  • Price Change: -5.4%
  • Signal: MACD_HISTOGRAM shows bullish divergence over 20 days while price fell 5.4% - potential bottoming signal

MFI - BULLISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 14 & 20 days
  • Price Change: -5.4%
  • Signal: MFI shows bullish divergence over 20 days while price fell 5.4% - potential bottoming signal

STOCH_K - BULLISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 14 & 20 days
  • Price Change: -5.4%
  • Signal: STOCH_K shows bullish divergence over 20 days while price fell 5.4% - potential bottoming signal

CCI - BULLISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 14 & 20 days
  • Price Change: -5.4%
  • Signal: CCI shows bullish divergence over 20 days while price fell 5.4% - potential bottoming signal

VOLUME_SMA_RATIO - BULLISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 14 & 20 days
  • Price Change: -5.4%
  • Signal: VOLUME_SMA_RATIO shows bullish divergence over 20 days while price fell 5.4% - potential bottoming signal

RSI_14 - BULLISH_DIVERGENCE

  • Confidence: 75.0/100
  • Timeframe: 14 days
  • Price Change: -2.3%
  • Signal: RSI_14 shows bullish divergence over 14 days while price fell 2.3% - potential bottoming signal

PRICE_SMA_RATIO - BULLISH_DIVERGENCE

  • Confidence: 75.0/100
  • Timeframe: 14 days
  • Price Change: -2.3%
  • Signal: PRICE_SMA_RATIO shows bullish divergence over 14 days while price fell 2.3% - potential bottoming signal

BEARISH DIVERGENCES (Potential Downside)

RSI_14 - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: RSI_14 shows bearish divergence over 30 days

MACD - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: MACD shows bearish divergence over 30 days

OBV - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: OBV shows bearish divergence over 30 days

MFI - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: MFI shows bearish divergence over 30 days

CCI - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: CCI shows bearish divergence over 30 days

PRICE_SMA_RATIO - BEARISH_DIVERGENCE

  • Confidence: 85.0/100
  • Timeframe: 30 days
  • Price Change: -6.8%
  • Signal: PRICE_SMA_RATIO shows bearish divergence over 30 days

INTERPRETATION GUIDE

Divergence Types:

  1. Classic Bearish: Price makes HIGHER HIGHS, indicator makes LOWER HIGHS
  2. Classic Bullish: Price makes LOWER LOWS, indicator makes HIGHER LOWS
  3. Hidden Bearish: Price makes LOWER HIGHS, indicator makes HIGHER HIGHS (continuation)
  4. Hidden Bullish: Price makes HIGHER LOWS, indicator makes LOWER LOWS (continuation)

Confidence Levels:

  • High (70+): Strong, clear divergence with significant price move
  • Medium (50-70): Clear divergence with moderate confirmation
  • Low (40-50): Early divergence signal, needs confirmation

TRADING IMPLICATIONS

Primary Signals (13 detected):

  • BULLISH_DIVERGENCE: 7 signals, strongest from MACD_HISTOGRAM (85.0/100 confidence)
  • BEARISH_DIVERGENCE: 6 signals, strongest from RSI_14 (85.0/100 confidence)

BULLISH BIAS: Consider looking for long entry opportunities on pullbacks. Multiple indicators suggest selling pressure is weakening.

KEY MONITORING LEVELS

  • Bullish Confirmation: Watch for price breakout above recent highs with increasing volume
  • Bearish Confirmation: Watch for price breakdown below recent lows with increasing volume
  • Invalidation: Divergence signals invalidated if price moves strongly in opposite direction

RISK MANAGEMENT NOTES

  1. Divergences are early warning signals, not entry signals
  2. Always wait for price confirmation before acting
  3. Consider multiple timeframe confirmation
  4. Strong trends can exhibit multiple divergences before reversing
  5. Use divergences to manage risk, not just for entries

This report is for technical analysis purposes only. Past performance is not indicative of future results.

News Agent Output

Summary

The news flow is surface-positive (6 positive, 0 negative) but the two highest-signal articles both report smart-money exits — Tepper liquidated his entire UNH position in Q2 and Berkshire had previously bailed — spun by retail-facing outlets as "did they make a costly mistake?" Underneath that spin, fundamentals are genuinely improving (MLR normalizing 88.9%→86.7%, operating margin 4.6%→7.1%, AI-driven cost efficiency, double-digit 2026 EPS growth) at a ~15x forward multiple. Net read: a real fundamental recovery, but a rebound that is already well-advanced, catalyst-poor into late October earnings, and being cheered by uniformly positive media — which is itself a caution flag.

Coverage Analysis

Normally covered, with a mild narrative spike. Ten articles over ~6 weeks is ordinary for a mega-cap, and roughly half are incidental mentions (ETF holdings, AbbVie/CVS comparison, an oil-stock piece). The dedicated coverage clusters around one debate: "billionaires sold, did they blow it?" This is a narrative-driven bump, not a data-driven one. The stock is not ignored and not crowded — it sits in the awkward middle where the easy re-rating story has already been told.

Sentiment Quality

The positive labels are mostly weak:

  • Reputation/PR filler: CIO speaking at an AI conference, "major player in AI medical coding market" (industry fluff).
  • Passive-flow mentions: top holding in SCHD and a dividend ETF — supportive but non-decisional.
  • Contrarian spin pieces: "Tepper sold — did he make a mistake?" and "Buffett bailed too soon?" are Motley Fool-style bull spins on the same bearish event.

The high-signal items are the capital allocation actions themselves, which are negative and are being laundered into positive headlines. There are zero negative articles — after a ~50% drawdown — which reads as media complacency, not genuine all-clear. By the prompt's own weighting (capital allocation > opinions), the quality of this positive sentiment is below average.

Dominant Narrative

"Turnaround / mean-reversion after the crash, validated by margin recovery — but the smart money already left."

Two sub-narratives in tension:

  1. Recovery (bullish): medical loss ratio normalizing, operating margin expansion, AI automation compressing claims costs, GLP-1 cost discipline, double-digit 2026 EPS growth at ~15x forward — a classic beaten-down-defensive re-rating.
  2. Smart-money exit (bearish): Tepper (100% exit) and Berkshire have both de-risked; media is now second-guessing them because the stock rallied.

Assessment: Mixed / strengthening toward bullish in headlines, but the capital-allocation undercurrent is quietly bearish. The "did they make a mistake?" framing means the media is now validating the rebound after the fact — usually a late-stage feature of a narrative, not an early one.

Signal vs Noise

High-signal (market-moving):

  • Tepper exits UNH entirely (Aug 26) — concrete allocation action by a top-tier manager; the article buries improving fundamentals inside a bull-spin frame.
  • "Rallied big since Berkshire bailed" (Jul 28) — hard fundamental data points (MLR, margins, forward earnings $25–30B, 15x P/E) plus a second smart-money exit.
  • "Sleep at night" (Aug 6) — confirms the 50% drawdown context and the durability of the dividend/balance sheet.

Low-signal (filler):

  • Cigna comparison (neutral, "me-too" competitor — confirms UNH's moat but no new info).
  • CIO AI conference (pure PR).
  • AI medical coding market report (generic industry TAM).
  • AbbVie/CVS and Buffett-oil-stock mentions (incidental).
  • Both ETF pieces (passive holdings, no active view).

Institutional Interpretation

A hedge fund would read this as: the easy money has been made. Two of the most respected allocators exited, and the stock has since "rallied big" — so the exits are stale/backward-looking, but they also mean the informed-money base has moved on. Fundamentals are improving for real, and 15x forward with double-digit EPS growth is not expensive. But there is no near-term catalyst (earnings 58 days out), the rebound is well-telegraphed, and coverage is uniformly positive with zero negative voices — a sentiment extreme that PMs treat as contrarian caution. The setup is asymmetric: media-bullish on the surface, quietly cautious underneath — "don't chase, but don't short a normalizing franchise either."

Trading Implications

  • Short-term (days–weeks): Neutral-to-cautious. No catalyst until late October; the rebound is extended and narrative-driven; positive-coverage saturation raises the risk of a consolidation/pullback. "Crowded long on the rebound" — not a fresh entry zone.
  • Medium-term (1–3 months): Constructive into the Oct 27 earnings catalyst. If MLR normalization and margin expansion are confirmed, 15x forward supports further upside and the Tepper/Berkshire exits look like early departures. Buy dips, not rips.

Final Sentiment Score

Neutral

Confidence: 62/100 (Bullish fundamental trajectory offset by stale-but-real smart-money exits, uniformly positive media, an already-extended rebound, and a 2-month catalyst vacuum.)

Market Regime Report

(Macro regime report as of 2026-08-26 -- 4 day(s) old as of 2026-08-30.) {"regime_label": "Disinflationary slowdown under a hawkish-hold Fed with low stress", "dominant_driver": "inflation", "regime_profile": {"growth": "decelerating", "inflation": "falling", "liquidity": "easing", "stress": "low"}, "key_tags": ["Liquidity Easing", "Disinflation Trend", "Inflation Persistence", "Low Volatility", "Elevated Term Premium", "Political Risk Elevated"], "confidence_score": 0.4, "forward_outlook": {"risk_off_probability": 0.35, "recovery_probability": 0.45}, "reasoning": "Growth is decelerating (payroll trends flat/negative, retail sales -0.58% m/m, Macro State growth factor at 25.6th percentile and falling), but unemployment at 4.10% and low claims keep it from being weak. Headline CPI is disinflating (3M annualized 0.49%) and PPI fell -0.78% m/m, while core PCE remains above target and PPI 6m is +7.76%, so the Fed's hawkish language is understandable: July minutes showed three dissents for a hike and Governor Cook says she is prepared to raise rates. The Macro State composite is 'DisinflationarySlowdown' for only one month, so it is a possible turn, not a confirmed regime; liquidity is easing and market risk is risk-on. Stress is low — VIX at the 12.3rd percentile, BAA-10Y at the 6.6th percentile since 2000, NFCI loose — but the re-steepened 10Y-2Y (+0.47pp) carries a validated forward drawdown-risk flag, the 10Y rise since Aug-2025 is ~80% term premium, and SKEW is elevated. The dominant tension is inflation/policy: the Fed is on a hawkish hold while the data and duration market are repricing disinflation and term premium.", "watch_signals": ["Core PCE m/m: sustained readings above ~0.25% would reinforce the hawkish-hold/hike bias", "Initial claims 4-week average: currently 204K; sustained rise above ~250K or Sahm >0.50 would flag labor stress", "BAA-10Y spread: currently 1.62%; break above the 12M range top ~1.70% would mark credit stress", "VIX: currently 15.21; close above 20 would signal a volatility-regime shift", "10Y term premium: currently 0.87%; continued rise beyond ~1.0% would pressure long duration and equity multiples"], "historical_grounding": {"equities_broad": {"bias": "mixed", "rationale": "SPY/QQQ are near 52-week highs with very tight credit (BAA-10Y at 6.6th pct since 2000, NFCI loose) and VIX at the 12.3rd pct, all supportive. But the re-steepened 10Y-2Y phase carries a statistically flagged forward drawdown risk, SKEW is elevated, and the regime is only one month old.", "precedent": "closest analog 2024-10-31 to 2026-04-30 (distance 0.566, 3m horizon); predictive_validation is NOT PREDICTIVE, so this is descriptive only.", "risk_flags": ["BAA-10Y spread breaks above ~1.70%", "VIX closes above 20", "10Y term premium continues to climb beyond 1.0%"]}, "gold": {"bias": "neutral", "rationale": "Gold at 4,648 is at the 99.0th percentile since 2000, yet the Historical Context Report flags it as diverging from its usual real-yield driver (10Y TIPS 2.32%, 90th pct) and the breakeven-inflation channel is too weak to assess (36m correlation -0.01). The level is historically extreme while neither conventional driver explains it; that divergence is more informative than a directional call.", "precedent": "closest long-horizon analog 2006-04-30 to 2007-09-30 (distance 0.986, 12m); descriptive only because validation is not predictive.", "risk_flags": ["Real yields fall sharply, re-coupling gold to its normal inverse relationship, could push gold higher", "Real yields keep rising would stress the stretched gold level", "Liquidity-driven equity drawdown forces gold liquidation"]}, "energy": {"bias": "mixed", "rationale": "WTI at 81.91 is at the 74.2nd pct since 2000 (91.2nd vs full history) but 3m/6m trends are -5.9%/-3.6%; Fed communications repeatedly cite Middle East conflict as an energy upside risk. Softening momentum vs geopolitical tail risk leaves the signal two-sided.", "precedent": "closest analog 2004-11-30 to 2005-03-31 (distance 0.929, 12m); descriptive only because validation is not predictive.", "risk_flags": ["Middle East escalation pushes oil through the upper 52-week range", "Global demand slowdown pulls oil below the 3m downtrend", "Tariff/supply-chain resolution removes the geopolitical premium"]}, "short_term_rates": {"bias": "neutral", "rationale": "Fed funds at 3.63% and the Macro State classifies liquidity as easing, but the July FOMC minutes were a hawkish hold (three dissents for a hike) and the 2Y at 4.17 (76.8th pct since 2000) sits above Fed funds, so the market is not pricing rapid easing. Direction depends on whether the disinflation pulse or the Fed's persistence concern wins.", "precedent": "closest disinflationary-slowdown analog 1991-05-31 to 1992-02-29 (distance 0.861, 12m); descriptive only because validation is not predictive.", "risk_flags": ["Core PCE m/m re-accelerates above ~0.3%", "FOMC speakers shift from 'prepared to hike' to an actual hike", "Sharp labor deterioration flips market to pricing cuts"]}, "long_term_rates": {"bias": "upside-biased", "rationale": "10Y at 4.64 is at the 81.5th pct since 2000, and the 10Y decomposition shows term premium (0.87%, 73rd pct since 2000) accounted for ~80% of the +0.44pp rise since Aug-2025; real 10Y is at the 90th pct. This is duration-risk compensation rather than a Fed-path repricing, and that premium can keep long yields elevated even if the Fed is on hold.", "precedent": "closest analog 1995-10-31 to 1996-12-31 (distance 0.891, 12m); descriptive only because validation is not predictive.", "risk_flags": ["Safe-haven bid on a growth shock unwinds term premium", "Fed signals actual easing and pulls the expected-path leg down", "Foreign demand for long Treasuries re-appears"]}, "dollar": {"bias": "neutral", "rationale": "Broad dollar at 118.06 is at the 74.5th pct since 2000, supported by very high US real yields (10Y TIPS 2.32%, 90th pct), but its 3m trend is -0.9% and the Macro State dollar factor sits at the 32.8th pct with a down direction. The US-G10 rate differential argues for support; momentum argues for softness.", "precedent": "closest analog 1991-05-31 to 1992-02-29 (distance 0.861, 12m); descriptive only because validation is not predictive.", "risk_flags": ["US real yields fall faster than G10 real yields", "Fed eases while other G10 central banks stay tight", "Risk-off shock triggers a safe-haven dollar bid despite the downtrend"]}}, "macro_state_echo": {"regime": "DisinflationarySlowdown", "months_in_regime": 1, "regime_established": false, "dominant_shock": "unclassified"}, "mapped_regime": {"label": "DISINFLATIONARY_SLOWDOWN", "confidence": null}}

Bear Output

看跌分析报告：联合健康集团 (UNH)

日期： 2026年8月30日
当前价格： $392.95
立场： 看跌 / 回避

核心论点

UNH 的反弹已进入后期阶段，聪明钱正在退出，技术面中期趋势转向下行，估值处于历史高位且盈利质量存疑，宏观利率环境形成逆风，同时短期缺乏正面催化剂。当前价格 $392.95 距离 7 月高点 $461.62 已回撤约 15%，而后续跌破近期支撑 $383.83 的风险显著，中期目标下看 $348.95（90 日交易区间下沿）。

一、估值过高与盈利质量隐患

  1. 市盈率处于历史高位
    当前 PE 为 25.22，处于 2016 年以来 75.7 百分位（历史均值 22.83，历史最高 38.04，最低 13.51）。在市场整体“反通胀放缓、鹰派联储”的背景下，高估值股票的倍数收缩压力更大。

  2. EPS 增长不可持续
    最新 EPS 为 $6.04，处于 85 百分位（历史均值 $4.05），但 1 年增长 +133.2% 建立在极低基数上，而 2 年增长为 -3.6%——盈利增长没有长期动能。PEG 0.19 看似便宜，实则是暴增 EPS 下的数学假象，一旦 EPS 回归常态增速，PEG 将迅速上升。

  3. 管理层情绪明显负面
    公司 2026Q2 财报电话会议中，Medicaid 总裁情绪得分仅 0.14，CFO 仅 0.32（中性为 0.5），表明内部管理团队对业务前景缺乏信心，尤其在 Medicaid 等政府业务板块。

  4. 内部人士持续卖出
    最近 90 天内，内部人士有两笔卖出记录：

    • 2026-08-21：卖出 1.2K 股，均价 $390.0
    • 2026-08-05：卖出 500 股，均价 $410.0
      虽然金额不大，但方向一致——内部人在股价反弹后选择减持，而非增持。

二、聪明钱集体撤离与媒体乐观悖论

新闻面表面呈 6 正 0 负的“全绿”，但高信号事件全部指向聪明钱退出：

  • David Tepper 在 Q2 清仓全部 UNH 持仓（2026-08-26 披露）。
  • 伯克希尔·哈撒韦此前已退出，而媒体随后用“他们是不是卖了之后错过反弹？”的论调来包装这一利空。

这种“把利空洗成利多”的叙事是典型的晚期反弹特征。当“错误卖出”成为媒体共识时，往往意味着反弹的知情买家已经不在场，后续买盘主要来自追涨的散户或被动资金。机构解读已明确指出：“容易赚的钱已经赚了”。

媒体情绪极端一致——零负面报道——本身就是一个反向警示。一个经历 50% 回撤后反弹的股票，没有任何质疑声音，意味着风险定价缺失。

三、技术面：中期空头趋势确立，反弹量能衰竭

  1. 中期趋势转空

    • 价格已跌破 50 日 EMA，当前 EMA50 值约为 $404（近端阻力），MACD 线位于零轴下方。
    • 摆动点序列显示：从 $461.62（7/16）→ $397.80（8/05）→ $383.83（8/20），形成高点下移、低点下移的空头结构。

  2. 量价背离与买盘枯竭

    • OBV 趋势向下，最近价格下跌伴随成交量萎缩（20 日均量比 0.61x，7 日均量 0.7x 50 日均量）。
    • 成交量分布显示当前价格 低于最大成交量 POC（$401.53），且 POC 上方堆积大量供应区（$394、$424、$416）。反弹需要消化层层压力，而低量环境下难以突破。

  3. 动量指标混杂但偏空

    • 30 日维度上，RSI、MACD、OBV、MFI、CCI 均出现 看跌背离（价格下跌但指标走弱）。
    • 20 日/60 日回报均为负（-5.40% / -0.89%），波动调整动量为负（-0.04），动量持续性“CHOPPY”。

  4. 关键点位

    • 阻力： $404.15 → $415.98 → $461.62
    • 支撑： $383.83（近期低点）→ $348.95（90 日区间下沿）
      若跌破 $383.83，下方低成交量缺口（$356.46）可能成为快速下跌通道。

四、宏观逆风：利率与政策压力

当前宏观状态为 “反通胀放缓 + 鹰派暂停”，对高久期股票不利：

  • 10 年期美债收益率 4.64%，处于 81.5 百分位，且上涨主要由**期限溢价（0.87%，73 百分位）**驱动。期限溢价上升直接压缩股票估值，尤其是医疗保健等长期现金流型标的。
  • 美联储 7 月会议纪要显示 3 位委员主张加息，Governor Cook 明确表示“准备加息”。若 9 月 16 日 FOMC 释放更鹰派信号，UNH 这类高 PE 股票将首当其冲。
  • 政治风险（关税、中东冲突）可能推升油价和通胀预期，进一步施压增长/估值。

宏观状态报告中“10 年期限溢价继续攀升至 1.0%以上”为明确风险信号，当前 0.87% 距离阈值不远。

五、催化剂真空与事件风险

  • 公司层面： 下一次财报在 10 月 27 日，距今 58 天。在此期间没有任何公司特定正面事件，股价缺乏向上驱动。
  • 宏观事件密集： 9 月 4 日非农、9 月 11 日 CPI、9 月 16 日 FOMC、9 月 30 日 PCE。若经济数据（核心 PCE 回升）或联储表态偏鹰，大盘及 UNH 将承压。
  • 期权到期结构显示 9 月 18 日为 四巫日，FOMC 与 CPI 均在到期前，波动可能放大，而当前 UNH 波动率处于低位区域，风险不对称。

六、结论与操作建议

结论： UNH 当前不具备看多条件。估值处于历史高位，盈利增长缺乏持续性；内部人和顶级机构在卖出；中期技术结构空头，量能萎缩；宏观利率上升压制估值；短期催化剂真空。虽然基本面（MLR、利润率）在恢复，但这一利好已被市场消化，且媒体全面乐观是反向信号。

操作建议：

  • 持仓者： 利用反弹至 $404-416 阻力区减仓或对冲。
  • 空仓者： 避免在当前价位追多，等待跌破 $383.83 确认信号后考虑做空，第一目标 $348.95，止损设于 $404 上方。
  • 风险关注： 若放量突破 $415.98，则空头逻辑减弱，需重新评估。

当前信号强度：看跌（中等置信度）。 下跌催化剂包括：宏观利率上行、内部人继续卖出、成交量持续萎缩。上行风险主要是超预期的财报或并购消息，但距离遥远。

数据截至 2026-08-30。

Bull Output

UNH 看多分析报告：被错杀的医疗巨头迎来结构性困境反转

分析师立场：看多 | 报告日期：2026-08-30

核心论点

UNH目前处于一个罕见的多周期共振窗口：基本面已确认拐点向上，而技术面正在完成中期回调的最后一跌，估值却仅为15倍远期市盈率。市场对"聪明钱离场"的叙事过度反应，忽略了一个关键事实——Tepper和Berkshire的退出是后视镜行为，而前瞻性指标（MLR正常化、利润率扩张、AI成本效率）正在全面改善。当10月27日财报确认这一轨迹时，当前$393的价格将成为新的起点而非终点。

一、宏观环境：医疗板块的顺风窗口正在打开

1.1 通胀回落利好医疗板块利润率

当前宏观特征为"反通胀放缓"（Disinflationary Slowdown），核心PCE增速回落，PPI环比下降0.78%。对于医疗健康行业而言，这意味着：

  • 医疗成本端压力缓解：UNH最大的成本项是医疗服务赔付（MLR），通胀回落直接减缓赔付增速，支撑MLR从88.9%向86.7%持续改善的趋势
  • 利率环境有利估值：美联储虽为鹰派持稳，但流动性评级为"宽松"（Easing），NFCI处于宽松区间，这对防御性成长股的估值带来结构性支撑
  • 防御属性溢价：在增长减速环境下，市场资金倾向于流向盈利确定性高的板块，UNH作为医疗保健龙头享有天然避风港溢价

1.2 市场压力处于低水平

VIX处于12.3百分位，BAA-10Y利差处于6.6百分位，市场风险偏好仍在。这意味着市场有充足的风险预算去追逐具有基本面催化剂的个股。对于UNH而言，一旦10月财报确认利润率修复的持续性，低波动的市场环境将放大其正面价格反应。

1.3 关键风险信号并未触发

宏观报告中的观察信号——BAA-10Y突破1.70%（当前1.62%）、VIX突破20（当前15.21）、初请失业金突破250K（当前204K）——均未触发。在信用利差保持紧缩、流动性宽松的环境下，融资成本可控，UNH的商业模式（先收保费、后付赔付）在正常信贷环境中具有天然的正现金流优势。

二、基本面：价值重估的核心驱动力

2.1 盈利拐点已确认，EP S增长133%

这是本报告最重要的数据点：UNH的EPS在一年内从约$2.59增长至$6.04，增幅达133.2%。这不是一个缓慢的均值回归，而是一次剧烈的盈利拐点确认。

指标数值历史百分位
EPS$6.0485.0% 🔴
PE25.2275.7% 🟠
PEG0.19极低
MLR（Q2）86.7%改善趋势
营业利润率（Q2）7.1%环比+250bp

PEG 0.19是核心估值信号。即使以保守的长期增长率假设（10-15%，而非当前的133%），PEG仍然远低于1.0，意味着当前价格存在显著折价。

2.2 经营质量实质改善，非一次性因素

2026Q2的改善是结构性的，而非一次性收益驱动：

  • MLR从88.9%降至86.7%：医疗赔付率改善220bp，直接反映承保质量提升和成本管控
  • 营业利润率从4.6%升至7.1%：250bp的利润率扩张在医疗健康行业极为罕见，表明AI驱动的理赔成本压缩和运营效率提升正在产生实际效果
  • AI医疗编码与成本效率：UNH在AI医疗领域的大量投入开始转化为可量化的成本节约，这是持续性的竞争优势，而非周期性波动

2.3 估值对比：15倍远期市盈率的防御股

UNH当前交易于约15倍远期盈利（基于2026年EPS约$26-30的共识区间）。考虑以下对比：

  • 标普500的远期市盈率通常为18-20倍
  • 医疗保健龙头（LLY、JNJ、ABBV等）平均远期市盈率为15-20倍
  • UNH的历史PE均值为22.83倍，中位数区间为17-26倍

当前估值远低于历史均值，却对应着远超历史平均的盈利增速。 当市场认识到MLR正常化和利润率修复是结构性而非周期性时，估值将向历史均值乃至更高水平回归。

三、竞争优势：不可复制的护城河

3.1 AI驱动的运营效率壁垒

UNH是唯一一个在全美范围拥有完整医疗服务链条（保险+医疗网络+数据分析）的企业。其AI能力不仅体现在内部成本控制上，还通过OptumHealth、OptumInsight等子公司对外提供AI驱动的医疗分析服务。这种数据-技术-服务的复合壁垒，是Cigna等竞争对手无法匹敌的（新闻中Cigna被描述为"me-too"竞争者即是明证）。

3.2 股息与资产负债表的"安心"属性

新闻报告中提到UNH的"sleep at night"特征：即使经历50%的回撤，其股息和资产负债表依然稳健。对于长期投资者而言，UNH提供了一个兼具成长性和防御性的稀缺组合——在宏观不确定性较高的环境下，这一属性具有溢价。

3.3 市场份额与定价权

UNH拥有医疗健康领域最大的网络规模和最高的客户留存率。在通胀回落、政策风险有所缓和的背景下，UNH的定价权优势将进一步转化为利润率的持续改善。

四、技术面：长期牛市趋势中的中期回调接近尾声

4.1 长期趋势结构仍然完整

尽管短期面临压力，但200日EMA的长期趋势保持强劲看涨：

  • EMA Gap为+10.59%，表明长期趋势方向明确向上
  • 120日回报率高达+39.18%，这是长期牛市的特征
  • 当前回调（20日-5.4%、60日-0.89%）发生在上升趋势中的正常回撤区间

4.2 多维度看涨背离信号正在聚集

技术分析报告中的看涨背离信号（Bullish Divergence）值得高度关注：

  • MACD柱状图、MFI、Stochastic K、CCI、RSI、成交量比率等多达7个指标在14-20天时间框架内同时出现看涨背离
  • 这些信号表明卖压正在衰竭，尽管价格仍在下跌，但内在动能已经开始转强
  • 这在Wyckoff分析中表现为"需求在下方累积、供应在上方消退"的典型底部结构

4.3 Wyckoff结构：价值区域内的吸收阶段

Wyckoff分析显示，当前价格位于价值区域（$363.97-$424.06）内部，且位于最大成交量POC（$401.53）下方。这正是机构投资者在价值区域内吸收筹码的典型特征：

  • 成交量持续萎缩（0.6x-0.7x均量），显示卖压枯竭
  • 低成交量节点分布在上方和下方，一旦突破将引发快速价格运动
  • 当前价格在支撑位$383.83上方获得支撑，"higher low"结构正在形成

4.4 短期动能转折信号

ADX为25.35（强趋势），RSI为42.31（中性偏弱，尚未超卖），但MACD柱状图正在转正。短期动能在20日看涨背离的背景下，很可能出现由下向上的趋势反转。

五、负面论点及回应

5.1 "Tepper和Berkshire已经卖出"

回应：这是后视镜行为，不是前瞻信号。

  • Tepper在Q2清仓UNH，Berkshire此前也退出，但两人都是在UNH处于低谷或反弹初期时做出的决策
  • 新闻标题本身已经承认"they sold — did they make a mistake?"，这说明在UNH随后上涨约50%之后，这些退出行为本身已被市场部分否定
  • 聪明资金并非永远正确。Tepper退出后UNH的涨幅证明了他的决策是过早的
  • 更重要的是，机构持仓的换手是常态。当一家公司的基本面正在改善时，新买家（包括被动资金和其他主动管理基金）会替代离场的旧买家

5.2 "没有短期催化剂"

回应：催化剂就在58天后，且当前正好提供了布局窗口。

  • 10月27日财报是关键催化剂。UNH在7月16日财报中已经超出共识29.8%，如果10月延续这一趋势，市场对MLR正常化和利润率修复的信心将进一步提升
  • 在催化剂到来前，当前价格正处于技术面回调的低位区域，提供了风险回报比最优的入场时机
  • 等待催化剂确认后再买入，意味着将支付更高的价格

5.3 "估值不便宜，PE处于75.7百分位"

回应：这是用历史数据看未来增速。

  • PE的75.7百分位是基于过去40个季度的分布。在此期间，UNH的EPS均值只有$4.05，而当前EPS为$6.04，增长49.3%
  • 正确的估值方式是以远期盈利增速来衡量。PEG为0.19，这是极端低估的信号
  • 当EPS继续增长（即使增速从133%回落至15-20%），PE将随着E的扩张而自然下降，无需担心过高估值

5.4 "新闻情绪过于统一正面，是反向指标"

回应：表面统一的正面情绪掩盖了高信号级的负面基础动作。

  • 新闻报告的核心发现是：正面文章质量弱（PR填充、被动持仓提及），而高信号级的资本配置行为是负面的（Tepper卖出）
  • 然而，这也意味着市场尚未完全定价改善的基本面。情绪的统一正面只是在描述已经发生的反弹，而非前瞻性的过度兴奋
  • 当媒体还在质疑"smart money为何离开"时，说明市场仍处于怀疑阶段。在牛市中，价格通常在"怀疑中上涨"，在"信心满满中见顶"

5.5 "宏观报告显示增长放缓，医疗板块可能承压"

回应：医疗健康板块对经济周期的敏感度极低。

  • UNH的核心业务是必要医疗服务，其需求并无弹性。经济放缓不会减少人们的就医需求
  • 实际上，在增长放缓、市场防御偏好上升时，医疗保健板块通常超额收益
  • 通胀回落对UNH的成本端是有利的，这一点在上面已经详细阐述

六、催化剂路径与操作建议

6.1 催化剂时间线

时间事件潜在影响
2026-09-04（5天后）非农就业数据若劳动力市场走弱，市场将预期美联储更早转向宽松，利好成长股估值
2026-09-11（12天后）CPI数据若通胀继续回落，提振利润率预期
2026-09-16（17天后）FOMC会议若释放鸽派信号，进一步降低贴现率
2026-10-27（58天后）UNH Q3财报核心催化剂。若延续MLR改善趋势，推动估值重估

6.2 策略建议

  • 短期（当前至10月）：利用技术面回调，在$385-395区间分批建仓。这是长期趋势中的价值区域，风险回报比最佳
  • 目标价参考：若10月财报确认盈利增长持续性，6-12个月目标价区间为$460-480（对应18-19倍远期EPS，仍低于历史均值22.8倍）
  • 止损参考：若价格跌破$383.83（近期摆动低点）且MACD转为深度负值，则需重新评估；但支撑位$359-364区域（价值区域下沿）是更合理的风险控制线

结论

UNH当前提供了一个罕见的多周期共振机会：

  1. 基本面拐点已确认（MRR正常化+利润率扩张+EPS增速133%），但市场仍在质疑其持续性
  2. 估值处于历史低位（PEG 0.19，远期PE 15倍），远未反映盈利改善的全部价值
  3. 技术面正在完成一个教科书式的底部结构（看涨背离+价值区域吸收+卖压枯竭）
  4. 负面因素（聪明钱离场）是后视镜信息，其影响已被市场消化
  5. 催化剂清晰（10月财报），等待期提供了一个低风险入场窗口

市场在犹豫中上涨。当10月财报确认基本面轨迹时，届时$393的价格将成为"当初应该买入"的位置。

免责声明：本报告仅为分析师观点，不构成投资建议。投资有风险，入市需谨慎。

Bear Rebuttal

{"rebutted": [{"bull_point": "以PEG 0.19、约15倍远期PE和EPS增长133%主张UNH基本面被严重低估", "rebuttal": "PEG 0.19是建立在不可持续的+133%一年增速上的数学假象——基本面报告同时显示2年EPS增速为-3.6%，盈利长期动能并未确认；当前PE 25.22仍处75.7百分位，并非低估值。新闻面也承认反弹'already well-advanced'且10月财报前无催化剂，而管理层电话会情绪分仅0.32/0.14、内部人持续卖出，内部信号并不支持'拐点被错杀'的重估逻辑。", "evidence_source": "Fundamental report, News agent report"}, {"bull_point": "7个14-20天看涨背离与Wyckoff价值区吸收构成底部结构，短期卖压枯竭", "rebuttal": "Divergence报告给出的净背离仅为+0.06（近似中性），且同一报告列出RSI、MACD、OBV、MFI、CCI、PRICE_SMA_RATIO共6个30日看跌背离，说明多头背离只是短周期冲突信号；Momentum报告总体NEUTRAL、中期BEARISH（价格位于EMA50下方、MACD为负），OBV下行，量能仅0.61x。Wyckoff显示价格低于POC $401.53、上方供应节点密集，且未检测到更高低点，不能判定底部。", "evidence_source": "Divergence report, Momentum report, Wyckoff analysis report"}], "conceded": [{"bull_point": "Tepper和Berkshire的退出是后视镜行为，股价随后的上涨已证明其离场过早", "concession": "接受这一时序批评：这些顶级机构的具体退出时点并非精确做空信号，用'聪明钱已走'作为即时看跌理由确实被弱化。对熊市论点的影响是下调'聪明钱'这一支柱的权重，但不否定当前持续的内部人卖出和10月财报前的催化剂真空。"}], "net_assessment": "熊市论点在核心估值与技术底部论上被有效反驳后仍为 INTACT，但聪明钱时序支柱被削弱；近期四次偏空/回避判断中三次命中，最近一次+0.7%的微小反向不足以趋势反转。"}

Bull Rebuttal

{"rebutted": [{"bear_point": "Tepper和Berkshire均已清仓UNH，媒体一致正面说明反弹已进入后期、没有后续知情买盘。", "rebuttal": "新闻报告将其定性为高信号但后视镜的资本配置事件：Tepper持仓是Q2披露，Berkshire退出后UNH已“大幅上涨”，媒体框架本身是“他们是否卖错了？”。报告最终情绪为Neutral，并明确称“不要做空一个正在正常化的龙头”，这与“没有买盘、反弹晚期”的结论并不一致。内部人两笔卖出仅1.2K和500股，对日均约4M成交的股票信息量很小；管理层情绪低分只出现在Medicaid总裁和CFO两个样本，更可能是Medicaid业务压力，不能外推为集团整体转向。", "evidence_source": "News agent report, Fundamental report (insider transactions, management sentiment)"}, {"bear_point": "技术面中期已转空：价格跌破EMA50，结构呈高点低点下移，OBV和量能背离表明上方供应沉重。", "rebuttal": "Momentum报告同时给出长期BULLISH（EMA Gap +10.59%，120日+39.18%）和短期“加速看涨”（MACD柱0.0691、ADX 25.35）；Wyckoff明确写“下方需求、上方供应—典型看涨结构”，且现价位于价值区间$363.97–424.06内部而非其下。Divergence报告是7个看涨对6个看跌，14–20日的看涨簇比30日的看跌簇更新。量能0.6x的下跌更像价值区吸收而非派发；近期DOWN单在414→390已实现，但最后一笔DOWN@390.11已+0.7%失手，说明$383.83/384.33附近的下跌动能正在衰竭。", "evidence_source": "Momentum report, Wyckoff analysis, Divergence report, decider track record"}, {"bear_point": "PE 25.22处于75.7百分位，EPS一年+133%是低基数/不可持续，两年-3.6%证实没有长期增长。", "rebuttal": "关键误读是把周期底形成的后视镜低基数与远期定价混在一起：新闻报告直接给出约15x远期市盈率和2026年EPS双位数增长，低于历史均值22.83x。Fundamental report标注“EPS Trend: strongly increasing”，当前6.04仅略低于区间高点6.91；两年-3.6%反映的是2025年医疗成本冲击造成的凹陷，而非增长停滞。PEG 0.19并非我的核心论据，即便按10–15%正常化增速，15x远期仍不昂贵。", "evidence_source": "News agent report, Fundamental report"}], "conceded": [{"bear_point": "10/27财报前有58天宏观催化剂密集窗口，9/16 FOMC、CPI/PCE和四巫日放大波动，且10Y期限溢价0.87%有继续上破1.0%的风险，高久期医疗股短期难有正向推手。", "concession": "这一点成立并降低近端确信度：在突破$404–416阻力前不应追高，应把建仓区缩窄到$383.83支撑附近、以$359–364价值区下沿为防线，等待宏观事件或财报确认。这意味着看多论点更依赖10/27催化剂，而非当前立即反转。", "evidence_source": "Event & Catalyst Calendar, Market Regime report"}], "net_assessment": "看多论点被削弱但尚未失效：核心路径仍在，但需以更保守的区间策略等支撑确认和10/27财报验证。"}

Group Decider Output

Debate summary: Bull 承认催化剂真空与宏观利率/事件风险并下调确信度；Bear 仅承认 Tepper/Berkshire 卖出时点不能作为精确空头信号，但其对估值（PE 75.7 百分位、2 年 EPS -3.6%）与中期技术（低于 EMA50/POC、OBV 下行）的反驳更强，净结果为 Bull WEAKENED、Bear INTACT。上周 DOWN@390.11 仅 +0.7% 小反向，但本周新增摆动低点 383.83、持续低于 POC/EMA50 且量能萎缩，并非旧论点简单复述，因此维持偏空但置信度中等。

Market summary: UNH 从 7 月高点 461.62 回撤至 392.95，处于 90 日区间 348.95-461.62 下沿、价值区 363.97-424.06 内且低于 POC 401.53。长期趋势仍多，但中期动能转空、量能萎缩小，新闻与基本面为中性偏谨慎，内部人连续卖出。10/27 财报前无公司催化剂，宏观事件密集。 Market state: Range-bound

Key levels

  • Support: S1 383.83 / S2 363.97
  • Resistance: R1 404.15 / R2 415.98

Directional view: BEARISH

Scenario analysis

  • Bullish: 放量收复并站稳 404.15 上方，确认突破近期摆动高点 → target 415.98
  • Bearish: 放量跌破 383.83 近期摆动低点 → target 348.95

Low-conviction zone: 383.83-401.53 (价格在近期摆动低点与 POC 之间，多空背离并存、量能萎缩，且 10/27 财报前无公司催化剂，方向读数弱、风险收益比差。) Confidence: Medium — Key risks: 宏观：鹰派联储、10Y 期限溢价 0.87% 逼近 1.0%；事件：9/16 FOMC、9/4 非农、9/11 CPI、10/27 财报；波动：9/18 四巫日、低量下价格易被放大。 Signal alignment: Mixed — 长期基本面修复与长期趋势偏多，但中期动量、量能、内部人卖出偏空，Wyckoff 处于区间内未形成一致方向。

Solo Decider Output

Market summary: UNH当前392.95美元，位于383.83-404.15核心区间内。基本面估值混合、新闻面表面偏多但聪明钱退出与内部人减持构成隐忧，动量长期偏多但中期偏空，多空背离并存。宏观处于低压力但鹰派观望的放缓环境，未来约两个月缺乏公司催化剂。上周看跌微错0.7%，但此前连续看跌兑现；本周不再坚持单边偏空，转为中性等待区间突破。 Market state: Range-bound

Key levels

  • Support: S1 383.83 / S2 348.95
  • Resistance: R1 404.15 / R2 415.98

Directional view: NEUTRAL

Scenario analysis

  • Bullish: 放量突破404.15且日线收于其上方，确认站上近期摆动高点 → target 415.98
  • Bearish: 跌破383.83且成交量放大，失守近期摆动低点与布林下轨支撑 → target 348.95

Low-conviction zone: 383.83-404.15 (价格位于价值区中部、POC之下，短期底部背离与中期顶部背离交织，成交量低迷，方向可信度低，需等待突破确认。) Confidence: Low — Key risks: 宏观：鹰派观望与期限溢价上行压制估值；事件：9/16 FOMC、9/11 CPI、10/27财报；波动：成交量极低且上下均有低量缺口，突破后可能加速。 Signal alignment: Conflicting — 长期趋势偏多、中期偏空、新闻面乐观但与聪明钱/内部人行为背离，短期指标多空不一。